Veterans' Pain Care Organizational Improvement Comparative Effectiveness Study (VOICE)
Chronic Pain
About this trial
This is an interventional treatment trial for Chronic Pain focused on measuring Opioid analgesics, Opioid partial agonists, Health care delivery, Back pain, Osteoarthritis, Veterans health
Eligibility Criteria
Inclusion Criteria:
- Moderate or high-dose long-term opioid therapy (≥ 20 ME mg daily for at least 3 months) for chronic pain
- Chronic pain of at least moderate severity (defined as pain that is present every or nearly every day for ≥ 6 months and with a score on the PEG 3-item pain measure of ≥ 5)
Exclusion Criteria:
- Dementia diagnosis
- Unstable or severe untreated psychiatric disorder, including severe untreated substance use disorder or active suicidal ideation
- Unstable or end-stage medical disease that would interfere with participation, including cancer requiring active treatment and life expectancy < 12 months
- Documentation of suspected controlled substance diversion
- Inability to communicate by telephone
Sites / Locations
- Minneapolis VA Health Care System
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Active Comparator
Active Comparator
Active Comparator
Telecare collaborative management (TCM)
Integrated pain team (IPT)
Standard taper options
Expanded taper options
Uses medication management approach delivered by a clinical pharmacist care manager with a collaborating physician to address common barriers to effective pain medication management in primary care.
Uses a biopsychosocial management approach delivered by a multidisciplinary team that emphasizes non-pharmacological pain management options.
The standard taper options arm uses patient education and shared decision-making to guide opioid medication management.
The expanded taper options arm uses patient education and shared decision-making to guide opioid medication management and includes the additional option of rotation to buprenorphine-naloxone.